Crossmark

CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive Atypia

Published Online: 2020-05-26

Published Print: 2020-12

Authors

Neal, Daniel J.

Amin, Mahul B.

Smith, Steven C. http://orcid.org/0000-0003-0982-4607
License Information

Text and Data Mining valid from 2020-05-26

Version of Record valid from 2020-05-26
More Information

Article History

Received: 18 February 2020

Accepted: 20 May 2020

First Online: 26 May 2020

Ethics approval and consent to participate

: This study was approved by the Virginia Commonwealth University RAMS-IRB under an expedited protocol with waiver of informed consent.

: Not applicable

: The authors declare that they have no competing interests.

Document is current